Epigenetic priming enhances antitumor immunity in platinum-resistant ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Epigenetic priming enhances antitumor immunity in platinum-resistant ovarian cancer

Published:2022-07-15 Issue:14 Volume:132 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Chen Siqi^ORCID,Xie Ping^ORCID,Cowan Matthew^ORCID,Huang Hao,Cardenas Horacio,Keathley Russell^ORCID,Tanner Edward J.^ORCID,Fleming Gini F.^ORCID,Moroney John W.^ORCID,Pant Alok,Akasha Azza M.,Davuluri Ramana V.^ORCID,Kocherginsky Masha,Zhang Bin^ORCID,Matei Daniela

Funder

USAMRMC/CDMRP

Diana Princess of Wales endowed Professorship and LCCTRAC funds from the Robert H. Lurie Comprehensive Cancer Center

Walter S. and Lucienne Driskill Immunotherapy Research fund

Astex Pharmaceutical, Inc.

Merck Sharp & Dohme Corp

National Cancer Institute

Office of the Provost, the Office for Research, and Northwestern University Information Technology

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/158800/files/pdf

Reference64 articles.

1. Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

2. Immunotherapy in ovarian cancer: we are not there yet

3. Pembrolizumab in patients with programmed death ligand 1–positive advanced ovarian cancer: Analysis of KEYNOTE-028

4. Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer

5. Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approaches to anticancer therapy based on modulation of DNA methylation;Siberian journal of oncology;2024-09-09

2. Macrophages and tertiary lymphoid structures as indicators of prognosis and therapeutic response in cancer patients;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

3. Epigenetic control of immunoevasion in cancer stem cells;Trends in Cancer;2024-09

4. A Predictive Model for Initial Platinum‐Based Chemotherapy Efficacy in Patients with Postoperative Epithelial Ovarian Cancer Using Tissue‐Derived Small Extracellular Vesicles;Journal of Extracellular Vesicles;2024-08

5. New hopes and promises in the treatment of ovarian cancer focusing on targeted treatment—a narrative review;Frontiers in Pharmacology;2024-06-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3